Finasteride and MENT Interaction

Compatible
Researched 90% confidence

Finasteride and MENT have a compatible interaction with 90% confidence. MENT is resistant to 5-alpha reductase and is not converted to a more potent androgen by this enzyme. As a result, finasteride has no meaningful interaction with MENT itself. If concurrent testosterone is being used, finasteride will still reduce DHT from that testosterone. Unlike with nandrolone, there is no paradoxical worsening of androgenic side effects when combining finasteride with MENT. These compounds primarily affect different organ systems.

Compound Profiles

Finasteride

5-Alpha Reductase Inhibitor | DHT Blocker for Hair Loss & BPH

Finasteride competitively and selectively inhibits the Type II isoform of the enzyme 5-alpha reductase, which is predominantly found in hair follicles, the prostate, and the liver. This enzyme converts testosterone into dihydrotestosterone (DHT).

Half-life: 6-8 hours (DHT suppression persists ~24 hours) Typical dose: 1mg/day (hair loss) or 5mg/day (BPH) hair loss
5 alpha reductase estrogenichepatotoxicteratogenic
View full profile

MENT

19-Nor Anabolic Steroid | Experimental TRT Alternative

MENT binds to the androgen receptor with high affinity, estimated at roughly 10 times the potency of testosterone, driving robust activation of AR-dependent gene transcription pathways responsible for protein synthesis, nitrogen retention, and satellite cell proliferation in skeletal muscle. Its 7-alpha methyl group renders it resistant to 5-alpha reductase, meaning it is not converted to a reduced metabolite in androgen-sensitive tissues the way testosterone is converted to DHT or nandrolone is converted to DHN.

Half-life: ~40 minutes (acetate ester) Typical dose: 5-25 mg/day (acetate) anabolic, sexual health
5 alpha reductaseandrogen receptorepo receptorestrogen receptor androgenicaromatase inhibitorblood pressure raisingcarcinogenic risk
View full profile

Combined Organ Load

Gonads
moderate
Heart
low
Skin
low
Liver
low

Shared Safety Flags

2x 2 estrogenic compounds (Finasteride, MENT). Combined estrogen elevation — monitor E2 and consider aromatase inhibitor.
2x 2 compounds share the teratogenic safety flag (Finasteride, MENT). Monitor accordingly.

Frequently Asked Questions

Can I take Finasteride with MENT?

Yes, Finasteride and MENT can generally be taken together. MENT is resistant to 5-alpha reductase and is not converted to a more potent androgen by this enzyme. As a result, finasteride has no meaningful interaction with MENT itself. If concurrent testosterone is being used, finasteride will still reduce DHT from that testosterone. Unlike with nandrolone, there is no paradoxical worsening of androgenic side effects when combining finasteride with MENT.

Is Finasteride and MENT safe together?

Based on documented research, this combination is considered compatible. However, shared safety flags include: estrogenic, teratogenic. Monitor accordingly.

What are the interactions between Finasteride and MENT?

MENT is resistant to 5-alpha reductase and is not converted to a more potent androgen by this enzyme. As a result, finasteride has no meaningful interaction with MENT itself. If concurrent testosterone is being used, finasteride will still reduce DHT from that testosterone. Unlike with nandrolone, there is no paradoxical worsening of androgenic side effects when combining finasteride with MENT. This assessment has 90% confidence and is based on documented research data.

How should I time Finasteride and MENT?

Finasteride has a half-life of 6-8 hours (DHT suppression persists ~24 hours) and MENT has a half-life of ~40 minutes (acetate ester). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: Finasteride vs MENT

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.